The European Union Council Recommendation of 2 December 2003 on cancer screening suggests the implementation of organised, population-based breast cancer screening programmes based on mammography every other year for women aged 50 to 69 years, ensuring equal access to screening, taking into account potential needs for targeting particular socioeconomic groups. A European survey on coverage and participation, and key organisational and policy characteristics of the programmes, targeting years 2010 and 2014, was undertaken in 2014. Overall, 27 countries contributed to this survey, 26 of the 28 European Union member states (92.9%) plus Norway. In 2014, 25 countries reported an ongoing population-based programme, one country reported a pilot programme and another was planning a pilot. In eight countries, the target age range was broader than that proposed by the Council Recommendation, and in three countries the full range was not covered. Fifteen countries reported not reaching some vulnerable populations, such as immigrants, prisoners and people without health insurance, while 22 reported that participation was periodically monitored by socioeconomic variables (e.g. age and territory). Organised, population-based breast cancer screening programmes based on routine mammograms are in place in most EU member states. However, there are still differences in the way screening programmes are implemented, and participation by vulnerable populations should be encouraged.
Introduction
Breast cancer screening programmes in Europe have been in place since the late 1980s, since results of trials on their effectiveness became available (Shapiro, 1977; Tabár et al., 1985; Andersson et al., 1988; Roberts et al., 1990; Tabár et al., 1992) . Surveys conducted in subsequent years (Jensen et al., 1990; Shapiro et al., 1998; Klabunde et al., 2002; Lynge et al., 2003; Yankaskas et al., 2004; Broeders et al., 2005; Klabunde and Ballard-Barbash, 2007 ) reported a gradual implementation of programmes, sometimes applying different policies, and heterogeneous compliance. At European Union level, the Council Recommendation of 2 December 2003 (Council of the European Union, 2003) (OJ L 327, 16.12.2003, p. 34 .) set a list of requirements for the implementation of organised, population-based breast cancer screening programmes; it represents a shared commitment by member states to implement cancer screening programmes. The Council Recommendation also recommended a breast cancer screening protocol 'foreseeing mammography screening for breast cancer in women aged 50 to 69 in accordance with European guidelines for quality assurance in mammography'.
The expected outcome of cancer screening programmes is a decrease in mortality rates for some types of cancer (von Karsa et al., 2008) ; however, participation in such programmes is key to attaining the expected outcomes. The different barriers to participation include: organisational aspects of the screening programmes; people's knowledge, beliefs and attitudes about the disease and the programmes; and lack of screening opportunities in some regions of Europe (Bastos et al., 2010) . Together, these barriers are shaping inequalities in cancer care.
Social inequalities in cancer imply health inequities spanning the full cancer continuum and cover social inequalities in the prevention, incidence, prevalence, detection and treatment, survival, mortality, and burden of cancer and other cancer-related health conditions and behaviours (Krieger, 2005) . Population-based screening programmes assure more equity in access in comparison with other health initiatives such as opportunistic screening programmes (Palència et al., 2010) . However, social inequalities in access can still be observed in population-based programmes , as shown by the fact that vulnerable populations -those who "because of shared social characteristics are at higher risk of risks" (Frohlich and Potvin, 2008 ) -participate less in breast cancer screening programmes. These groups include those with lower socioeconomic status, and those pertaining to minority ethnic groups (von Euler-Chelpin et al., 2008; Szczepura et al., 2008) . Equity aspects are considered in the Council Recommendation, which ask for 'action to be taken to ensure equal access to screening, taking due account of the possible need to target particular socioeconomic groups' (Council of the European Union, 2003) .
In 2008, a first report of the implementation of the Council Recommendation was issued (von Karsa et al., 2008 ) (hereinafter Implementation Report). It was based on a written survey involving the EU member states, conducted by the European Commission's Directorate-General for Health and Food Safety (DG SANTE) in the second half of 2007, and complemented by information obtained from two European projects (European Cancer Network -ECN, and European Network for Information on Cancer -EUNICE). The Implementation Report stated that most member states had followed the Council Recommendation, and that most of them intended to undertake future actions. Data collected through EUNICE, also published by Giordano et al. (Giordano et al., 2012) in 2012, referred mostly to 2005 , 2006 and 2007 . In 2010 , the first wave of the Eurostat European health interview survey (EHIS) (Eurostat, 2010 ) asked for few variables related to cancer screening (percentage of women who had undergone a mammography and, if a woman had undergone a mammography, what her reasons for doing so were); most countries reported data up to 2008 or 2009. While a second Implementation Report is in preparation (DG SANTE Grant Agreement 2011 53 03), no consistent data were available after 2010. In 2014 a new survey was undertaken in order to provide bridging on some general indicators on breast cancer screening programmes in Europe, and to provide original data on equity of access to those programmes.
Methods
Contacts within each member state were derived from two independent surveys conducted by the European Commission's Joint Research Centre (JRC) in 2012 (European Commission Initiative on Breast Cancer, 2015; Lerda et al., 2014) , and the Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO) within the European Partnership for Action Against Cancer (EPAAC) framework. Further details on those surveys are reported in Appendix A.
Data collection
Contributors to the two previous surveys received a joint communication from the JRC and FISABIO in July 2014, asking if they were interested in providing data for the publication of a common research paper. Each country was asked to provide a unique contact person and the names of up to two additional contributors (with the exception of countries with regional screening programmes, which were allowed more contributors). These persons were held responsible for checking and integrating the information reported in the past two survey(s) they had contributed to, according to standardised definitions provided in a new questionnaire. Definitions from the EUNICE project (EUNICE, 2012) and the Implementation Report (von Karsa et al., 2008) were applied when relevant. All countries except one that had participated in previous surveys agreed to contribute to the new paper.
Data analysis
A descriptive study of the main variables included in the questionnaire was performed. Calculations for the total number of women in the eligible population, total number of women invited and total number of women screened only considered the data available for the countries/regions providing information. Coverage by invitation, coverage by test, and participation rate were computed using EUNICE's formulas for an annual period (EUNICE, 2012) . Coverage was defined as the extent to which the screening programme covers the eligible population within the appropriate interval in a given period by invitation (invitation coverage), and the extent to which the screening programme covers the eligible population with screening tests (examination coverage). Coverage by invitation was calculated as the annual number of invitations divided by the annual target population; coverage by test was calculated as the annual number of women screened divided by the annual target population. Participation is defined as the proportion of women personally invited for screening who actually attended, and was calculated by dividing the annual number of women screened by the annual number of invitations.
Results

Respondents
Twenty-seven countries contributed to this survey, 26 of the 28 member states (92.9%) (no data from Greece or Slovakia) plus Norway. Data covering the whole state was provided by all the surveyed states, with the exception of United Kingdom (England only), Portugal (four regions out of seven), and Spain (15 regions out of 19). All the countries contributed both information for 2010 and 2014 about the screening organisation and protocol; regarding performance indicators, 20 countries contributed with 2014 data, three with 2013, three with 2012 and one with 2011. On inequality issues, all countries reported data for the 2010-2014 period except Romania (its programme began in 2014). Information on interventions to tackle inequalities was provided separately for the 2007-2012 and 2012-2014 periods.
General characteristics
General information on screening policy is reported in Table 1, Table  2 and Fig. 1 . Most screening programmes started in the first decade of this century, with the exception of Sweden (1985) , Finland (1987) , England (1988) , the Netherlands (1990 ), Denmark (1992 , Luxembourg (1992) , Norway (1996) and more recently Austria (2010) and Bulgaria (2013) [data not shown] . By 2010, 20 countries had rolled-out a population-based programme (in Portugal only for the Central Region, Alentejo and Algarve); in 3 countries (Malta, Poland and Slovenia), as well as for the Northern Region of Portugal, the rollout was ongoing. In three countries the programme was in its pilot (Austria, Czech Republic) or planning (Bulgaria) phase. In 2014, Malta and Poland completed the rollout, Bulgaria started a pilot and Romania initiated planning, which corresponds to 24 countries having a fully implemented population-based breast cancer screening programme. In 2014, a national programme or a regional programme with national coordination (Denmark, Portugal) was present in all countries; only Belgium Table 1 Breast cancer screening programmes in 2010 and 2014. Programme type: NP = Non-programme screening. Examinations for early detection of breast cancer performed in a diagnostic or clinical setting, independent from the public screening policy P = Programme screening. Examinations financed by public sources performed in the context of a public screening policy documented in a law, or an official regulation, decision, directive or recommendation, and where the policy defines, at minimum: the screening test, the examination intervals, group of persons eligible to be screened O = Organised screening. Programme screening where other procedures (e.g. standard operating procedures) are specified and where a team at national or regional level is responsible for implementing the policy PB = Population-based screening. Programme screening where in each round of the screening the persons in the eligible target area served by the programme are individually identified and personally invited NA = Not applicable Coordination: NS = National screening programme; R/NC = Regional screening programme, nationally coordinated; R = Regional screening programme; L, N/RC = Local screening programme, regional/national coordinated; L = Local screening programme; NA = Not (whose performance data are reported separately for Brussels, Flanders and Wallonia) and Spain had regional screening programmes in place. The planned project in Romania has regional coordination; Austria switched from local/national or regional coordination to national coordination between 2010 and 2014. National and regional websites are listed in Appendix B.
Screening protocol
The screening method used most often (Table 1 and Table 2 ) is mammography alone, with the exception of France, which implements mammography plus clinical breast examination. A specific question on analogic vs. digital mammography was not included in the survey, but this information was voluntarily reported by some countries. Regarding the target age, Portugal, Austria, Spain and Italy have different protocols according to the region. Women have been targeted from at least age 50 in all countries with active programmes since 2010 but Malta; a lower target age was applied in 7 countries/regions either in 2010 or 2014 (from age 40 or 45 according to the specific protocol). In 2010, three countries (France, the Netherlands, Sweden) were inviting the over 70s for screening, a number that increased to five countries in 2014 with the inclusion of some regions in Italy and Austria. Overall, the target age specified in the Council Recommendation (50-69 years) was Government announced plans to extend its breast cancer screening programme to women aged 65-69, commencing in 2015. The screening interval is two years in most countries except for Bulgaria, England and Table 3 shows the number of women invited and tested each year per country, as well as the calculated coverage by invitation and participation rate, and coverage by test. The number of people invited per year depended mostly on the country's population and the programmes' coverage -ranging from 11864 (Malta, rollout ongoing in 2010) tõ 4.800,000 in France and in Germany. The total number of women in the overall target population that was used to calculate coverage rates was 28 million in 2010 (data from 23 countries, plus two regions of Belgium) and 29 million in 2012-2014 (latest annual update from 23 countries, plus one region of Belgium). The total number of invitations was 24 million in 2010 (data from 24 countries) and 26 million in 2012-2014 (latest annual update from 24 countries, plus two regions of Belgium). Finally, the number of women screened was 14 million in 2010 (data from 24 countries) and 16 million in 2012-2014 (latest annual update from 25 countries). For some countries the invitation strategy does not include an individual letter and the rates were not computed in the same way as for the others: in the Czech Republic, women previously accessed the programme without a personal invitation letter and those who had not previously attended were only invited to do so from 2014; in Lithuania the invitation is sent by the general practitioner and is registered only when the mammography test is carried out; for Finland, annual coverage by invitation and by test are approximated, as some municipalities use different invitation schedules over the two-year round. Coverage by invitation was higher than 90% in 17 countries, both in 2010 and in 2014.
Coverage by invitation
Comparing coverage by invitation in 2014 with that in 2010, the greatest increase is observed in countries implementing the rollout within this period (2010-2014) as opposed to countries that had already implemented screening before 2010. Significant increases were seen in: Estonia, from 83.9% to 92.1%; Malta, from 55.5% to 100.0%; Slovenia: from 9.8% to 28.3%. However, differences among countries and between 2010 and 2014 may be due to differences in the timing of invitations in individual countries.
Participation rate
As regards the participation rate, in 2010 six countries/regions (Denmark, England, Finland, the Netherlands, Sweden and Slovenia) reported a rate above 75%, which is the desirable threshold for the corresponding indicator in the European Guidelines for quality assurance in breast cancer screening and diagnosis (hereinafter European Guidelines) (Perry et al., 2006) . In general, no major differences in individual countries' participation rates were observed between 2010 and 2014 for most of those countries where the rollout had already been completed in 2010. Another three countries (Ireland, Norway and Spain) report a rate above 70%, which was an acceptable level according to the European Guidelines. Therefore, there are nine countries with a better than acceptable level of participation. The latest corresponding figure is comparable, with Ireland reaching N75% in 2014. As for the invitations, differences between countries, and between 2010 and 2014 for individual countries, may be due to differences in the timing of invitations and registration of test uptake.
Coverage by test
Finally, coverage by test, which depends on the previous indicators, ranged from 7.9% in 2010 (Slovenia, rollout ongoing) to 81.4% (England) in 2010 and from 1.0% (Bulgaria, pilot) to 80.0% (Sweden) in 2014.
Equity and access
Inequalities in access were identified. Although accessing most of the programmes is free of charge (Table 4 ) (with the exception of Norway), 16 have programmes that do not cover certain social groupsmost frequently women without health insurance, women without residence permits, and women in prison. Some 16 programmes do however have specific objectives to reduce inequalities. These objectives are general (both general and targeted) in seven countries, targeted in four countries, and complementary in five countries.
To monitor participation (Fig. 2) , most countries use socioeconomic variables. All countries monitor participation by age and territory, and half of them also include other variables, such as socio-economic level, educational level and/or ethnicity/nationality. Moreover, 13 countries have identified vulnerable populations that participate to a lesser extent in their programmes (Fig. 2) , with the deprived population and migrant/ethnic minority groups being the population groups most commonly identified, followed by older women and those with a lower level of education. On the other hand, 18 countries identified barriers to participation (Fig. 2) , with beliefs, knowledge and accessibility being the barriers most commonly detected. Finally, 17 countries have acted to tackle inequalities in participation. The majority of such interventions were performed in the period 2007-2012 -nine countries performed no such intervention in 2012-2014 (Table 5) . Interventions directed to the general population were the most frequent. Examples of interventions (Table 5) are: information strategies (e.g.: general information campaigns, informative materials adapted to the needs of specific population groups, information sessions, community courses); organisational changes (e.g.: establishment of population-based screening programmes); accessibility improvements (e.g.: decrease in transport barriers, removal of fees, facilitation of out-of-hours appointments, establishing mobile units in rural areas and targeting ethnic communities); invitation strategies (e.g.: follow-up calls to non-attendants); social participation mechanisms and empowerment (e.g.:
Notes to Table 3: a Women previously not attending individually invited Jan-Dec 2014, coverage computed for total target population 45-70 (entire population targeted in 2014). b In Finland, some municipalities invite women aged 51-69 years every two years, others invite women aged 50-68 years every two years. Therefore, the coverage of invitations and visits (or tests) must be calculated over a two year period. Thus the coverage of invitation calculated using numbers from the year 2010 would not give a real picture on the invitational coverage of the national programme in age group 50-69 in 2010. Additionally, the programme expands gradually in ages 60-69 until 2016. c Non-adjusted target population. d The presented data refer to the target population and are derived from the statistical offices of the federal states without adjustment for eligibility. Women with one of the following criteria are not eligible and excluded temporarily: women with mammogram within the last 12 months, women with symptoms for breast cancer and women with breast cancer and in breast cancer care. Exact adjustment for eligibility as well as complete access to the target population is not possible due to very strict data protection regulations. e There is no systematic personal invitation system through population register, but via GP's. training health agents from local ethnic groups, social inclusion work); monitoring and research (e.g.: participation monitoring in specific geographic locations, studies of reasons for non-attendance).
Discussion
Population-based breast cancer screening is now in place in nearly all EU member states. By 2014, in 23 out of 28 member states, the rollout of an organised or population-based programme was complete (82.1%), in 2 the rollout was ongoing (7.1% -Slovenia and Northern Region of Portugal), 1 country was piloting a programme (Bulgaria), and another was planning to pilot a programme (Romania). For the two remaining countries (Greece and Slovakia), for which no data were provided, the most recent international source of information on screening programmes (von Karsa et al., 2008; Lerda et al., 2014) provided no evidence that an organised breast cancer screening programme was in place or planned, although some evidence exists for Greece (Simou et al., 2011; Trigoni et al., 2008; Trigoni et al., 2011; Tsounis et al., 2014) . The present results are consistent with the findings in the Implementation Report (von Karsa et al., 2008) . They show a positive trend towards compliance with the Council Recommendation and are encouraging, especially when considered together with the recent data on organised breast cancer screening in non-EU Mediterranean countries (Giordano et al., 2016) , where such programmes are rare and do not meet international recommendations. In particular, only 4 out of the 25 countries with a programme in place do not cover the 50-69 age group, whilst the eligible age in 7 countries extends above or below this age threshold. It is worth noting the recent IARC viewpoint (LaubySecretan et al., 2015) , which suggests there is sufficient evidence of mortality reduction for women aged 70-74, whilst for women aged 45-49 the evidence is limited. Moreover, three countries employ a different invitation schedule, using baseline risk as defined by breast density and/or specific age groups. In the Implementation Report there was no evidence of tailored screening protocols in place in organised programmes, which may reflect that research activity on tailored screening is still ongoing (Paci and Giorgi Rossi, 2010) .
Taking into account the overall results of the 20 countries/regions that provided complete data for 2010 and 2014 (see Table 3 , i.e. Austria, Belgium -Brussels, Croatia, Cyprus, Estonia, Finland, France, Germany, Ireland, Italy, Luxembourg, Latvia, the Netherlands, Norway, Poland, Portugal, Spain, Sweden, Slovenia, England), mean coverage by invitation increased by 3% (86.8% to 90.1%), and coverage by test by 4% (48.3% to 52.6%). This increase seems to be mainly due to progress or completion of rollout in Austria, Latvia, Italy, and Slovenia. Globally, coverage by invitation and by test still seems to be improving slightly, despite the austerity measures implemented in Europe over the last five years. However, the large range observed for the indicators in different countries (e.g. participation rate ranging from 8.3% to 84.8% in 2010 and It is widely accepted that European health care policies, such as 'universal' national health systems and 'population-based' cancer screening programmes, promote equity. However, vulnerable populations have been identified as being excluded from the target population (e.g.: women without health insurance, women without residence permits, and women in prison). According to the definition of target population included in the European Guidelines (Perry et al., 2006) , 'all women eligible to attend for screening on the basis of age and geographic location (dictated by screening policy)' shall be invited. This definition also specifies that 'special groups such as institutionalised or minority groups' should be included. It would therefore be advisable for European breast cancer screening programmes to ensure that the definition of their target population is in accordance with the European Guidelines, including that for vulnerable populations.
Monitoring participation is another quality indicator recommended in the European Guidelines (Perry et al., 2006) . Age and territory are the most common variables used to analyse participation, but effort is needed to also include variables related with ethnicity and socioeconomic level in cancer screening registries. This study identified inequalities in participation, with socially vulnerable groups showing a lower participation rate. These results are consistent with those of other studies (Palència et al., 2010; Euler-Chelpin et al., 2008; Dolansky, 2006; Maheswaran et al., 2006) . Reducing social inequalities in cancer could be achieved with different approaches, both general and targeted. The general approach takes into account the whole population, and seeks to reduce the difference in health between high, middle and low-income groups by providing health opportunities equally across all socioeconomic strata. The targeted approach focuses only on people in the poverty stratum. Both approaches are complementary and interdependent (Whitehead and Dahlgren, 2006) . Interventions to tackle inequalities with general and targeted approaches are therefore needed.
This study reports the implementation status of breast cancer screening programmes in most EU countries. However, as the Council Recommendation invited to maximise benefits and minimise harms of screening and to comply with quality assurance guidelines, our study is limited to some extent by a lack of information on the quality of the service actually provided by those countries. This is important, particularly in view of the debate on the undesirable effects of mammography screening, such as overdiagnosis.
Despite continuous improvement in the implementation of breast cancer screening programmes, it may be challenging in future to maintain the coverage achieved despite austerity, to reduce inequalities in access, and to maximise the risk-benefit ratio. Moreover, strategies to reduce inequalities in cancer screening must be implemented. For this to happen, the unequal distribution of barriers limiting access to screening among different socioeconomic and cultural groups must be further analysed so that suitable interventions that improve access to good quality screening may be developed.
Conclusion
Organised, population-based breast cancer screening programmes based on routine mammograms are in place in most EU member states. However, there are still differences in the way breast cancer screening programmes are implemented which could translate into cancer inequalities. Offering universal and free access to breast cancer screening and implementing interventions to encourage participation by vulnerable populations through information and invitation strategies as well as social participation and empowerment mechanisms will be needed. In the future, studies on the quality of the services provided will also be necessary. 
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